These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 31256656)

  • 1. 2019 John Insall Award: Fructosamine is a better glycaemic marker compared with glycated haemoglobin (HbA1C) in predicting adverse outcomes following total knee arthroplasty: a prospective multicentre study.
    Shohat N; Tarabichi M; Tan TL; Goswami K; Kheir M; Malkani AL; Shah RP; Schwarzkopf R; Parvizi J
    Bone Joint J; 2019 Jul; 101-B(7_Supple_C):3-9. PubMed ID: 31256656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Fructosamine: A Simple and Inexpensive Test for Assessing Preoperative Glycemic Control.
    Shohat N; Tarabichi M; Tischler EH; Jabbour S; Parvizi J
    J Bone Joint Surg Am; 2017 Nov; 99(22):1900-1907. PubMed ID: 29135663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated HbA1c is not a risk factor for wound complications following total joint arthroplasty: a prospective study.
    Citak M; Toussaint B; Abdelaziz H; Klebig F; Dobinsky A; Gebauer M; Gehrke T
    Hip Int; 2020 Sep; 30(1_suppl):19-25. PubMed ID: 32907422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal haemoglobin A1c screening reveals high prevalence of dysglycaemia in patients undergoing total knee arthroplasty.
    Chan VWK; Chan PK; Woo YC; Fu H; Cheung A; Cheung MH; Yan CH; Chiu KY
    Hong Kong Med J; 2020 Aug; 26(4):304-310. PubMed ID: 32764157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do glycemic markers predict occurrence of complications after total knee arthroplasty in patients with diabetes?
    Hwang JS; Kim SJ; Bamne AB; Na YG; Kim TK
    Clin Orthop Relat Res; 2015 May; 473(5):1726-31. PubMed ID: 25404402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment.
    Konya J; Ng JM; Cox H; Cooke M; Lewis N; Bhandari S; Atkin SL; Kilpatrick ES
    Diabet Med; 2013 Oct; 30(10):1250-4. PubMed ID: 23758176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between glycated haemoglobin, glycated albumin and fructosamine with neonatal birthweight and large-for-date status infants in gestational diabetes mellitus: a prospective cohort study.
    Mendes N; Alves M; Andrade R; Ribeiro RT; Papoila AL; Serrano F
    J Obstet Gynaecol; 2019 Aug; 39(6):768-773. PubMed ID: 31007102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fructosamine is a valuable marker for glycemic control and predicting adverse outcomes following total hip arthroplasty: a prospective multi-institutional investigation.
    Shohat N; Goswami K; Breckenridge L; Held MB; Malkani AL; Shah RP; Schwarzkopf R; Parvizi J
    Sci Rep; 2021 Jan; 11(1):2227. PubMed ID: 33500515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between fasting plasma glucose, post prandial glucose and glycated haemoglobin and fructosamine.
    Rosediani M; Azidah AK; Mafauzy M
    Med J Malaysia; 2006 Mar; 61(1):67-71. PubMed ID: 16708736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determining the Threshold for HbA1c as a Predictor for Adverse Outcomes After Total Joint Arthroplasty: A Multicenter, Retrospective Study.
    Tarabichi M; Shohat N; Kheir MM; Adelani M; Brigati D; Kearns SM; Patel P; Clohisy JC; Higuera CA; Levine BR; Schwarzkopf R; Parvizi J; Jiranek WA
    J Arthroplasty; 2017 Sep; 32(9S):S263-S267.e1. PubMed ID: 28662955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical outcomes of total knee replacement according to diabetes status and glycemic control, 2001 to 2009.
    Adams AL; Paxton EW; Wang JQ; Johnson ES; Bayliss EA; Ferrara A; Nakasato C; Bini SA; Namba RS
    J Bone Joint Surg Am; 2013 Mar; 95(6):481-7. PubMed ID: 23446446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing glycaemic control in diabetes: relationships between fructosamine and HbA1C.
    Braatvedt GD; Drury PL; Cundy T
    N Z Med J; 1997 Dec; 110(1057):459-62. PubMed ID: 9451409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unicondylar Knee Arthroplasty Has Fewer Complications but Higher Revision Rates Than Total Knee Arthroplasty in a Study of Large United States Databases.
    Hansen EN; Ong KL; Lau E; Kurtz SM; Lonner JH
    J Arthroplasty; 2019 Aug; 34(8):1617-1625. PubMed ID: 31064725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prior hip or knee prosthetic joint infection in another joint increases risk three-fold of prosthetic joint infection after primary total knee arthroplasty: a matched control study.
    Chalmers BP; Weston JT; Osmon DR; Hanssen AD; Berry DJ; Abdel MP
    Bone Joint J; 2019 Jul; 101-B(7_Supple_C):91-97. PubMed ID: 31256641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can plasma fructosamine substitute for glycated haemoglobin (HbA1c) estimation in the assessment of diabetic control?
    Malik M; Gill GV; Pugh RN; Bakir A; Hossain M
    Trop Doct; 2000 Apr; 30(2):74-6. PubMed ID: 10842549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relations between long-term glycemic control and postoperative wound and infectious complications after total knee arthroplasty in type 2 diabetics.
    Han HS; Kang SB
    Clin Orthop Surg; 2013 Jun; 5(2):118-23. PubMed ID: 23730475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycaemic indices and non-traditional biochemical cardiovascular disease markers in a diabetic population in Nigeria.
    Ogbera OA; Azenabor A
    J Coll Physicians Surg Pak; 2011 Aug; 21(8):455-9. PubMed ID: 21798129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycaemic markers and all-cause mortality in older adults with and without diabetes: the Atherosclerosis Risk in Communities (ARIC) study.
    Rooney MR; Tang O; Pankow JS; Selvin E
    Diabetologia; 2021 Feb; 64(2):339-348. PubMed ID: 32990802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of random blood glucose as a predictor of the quality of glycaemic control by glycated haemoglobin in out-patient diabetic patients at Kenyatta National Hospital.
    Otieno FC; Ng'ang'a L; Kariuki M
    East Afr Med J; 2002 Sep; 79(9):491-5. PubMed ID: 12625691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.